"DNA Methylation signatures in panic disorder".
Iurato, Stella; Carrillo-Roa, Tania; Arloth, Janine; Czamara, Darina; Diener-Hölzl, Laura; Lange, Jennifer; Müller-Myhsok, Bertram; Binder, Elisabeth B; Erhardt, Angelika.
; 7(12): 1287, 2017 12 18.
Artigo em Inglês | MEDLINE | ID: mdl-29249830
The norepinephrine transporter gene is a candidate gene for panic disorder.
Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder.
Candidate genes in panic disorder: meta-analyses of 23 common variants in major anxiogenic pathways.
Gender-specific association of variants in the AKR1C1 gene with dimensional anxiety in patients with panic disorder: additional evidence for the importance of neurosteroids in anxiety?
Asymmetry of prefrontal cortex activities and catechol-O-methyltransferase Val158Met genotype in patients with panic disorder during a verbal fluency task: near-infrared spectroscopy study.
Potential involvement of NET polymorphism in serotonin/norepinephrine reuptake inhibitor response in panic disorder.
The effects of the catechol-O-methyltransferase val158met polymorphism on white matter connectivity in patients with panic disorder.
Association between genes on chromosome 19p13.2 and panic disorder.
Facilitation of 5-HT1A-mediated neurotransmission in dorsal periaqueductal grey matter accounts for the panicolytic-like effect of chronic fluoxetine.
Is the Val66Met polymorphism of the brain-derived neurotrophic factor gene associated with panic disorder? A meta-analysis.